Past Events

  • Read more: Health Law Year in P/Review
    Feb 1 2013

    Health Law Year in P/Review

    2012 was an historic year for health law, with the Supreme Court issuing the final word on the constitutionality of the Affordable Care Act alongside a host of other critical developments. 2013 promised to continue the trend, with a number of other important topics on the horizon, from employer coverage of contraceptives to gene patenting…

  • Read more: Food & Drug Law, Past, Present, & Future: Celebrating Peter Barton Hutt’s 20 Years (thus far) at HLS
    Jan 17 2013

    Food & Drug Law, Past, Present, & Future: Celebrating Peter Barton Hutt’s 20 Years (thus far) at HLS

    Peter Barton Hutt has worked at the Washington, DC law firm of Covington & Burling, specializing in Food and Drug Law, for more than five decades. He has represented clients in administrative, legislative, executive, and judicial settings. He began his law practice with the firm in 1960 and is now Senior Counsel; between 1971 to…

  • Read more: Nourishing a Legal Career in the Life Sciences
    Nov 29 2012

    Nourishing a Legal Career in the Life Sciences

    A career discussion with Amy Schulman, Lecturer on Law at HLS, Executive Vice President and General Counsel at Pfizer, Inc., President and General Manager of Pfizer Nutrition, and Mark Nance, Senior Vice President and General Counsel at Mylan, Inc. The discussion was moderated by Professor David Wilkins. Co-sponsored by the Program on the Legal Profession, the Petrie-Flom Center for…

  • Read more: Stem Cell Therapy and Medical Tourism: Of Promise and Peril?
    Nov 28 2012

    Stem Cell Therapy and Medical Tourism: Of Promise and Peril?

    Experimental breakthroughs within the field of regenerative medicine are reported in the media on a daily basis worldwide. Despite this progress, the overwhelming majority of clinical problems for which stem cell-based intervention offers hope remain therapeutically unproven, and a major gap exists between current public understanding and the availability of innovative therapies. This event featured…

  • Read more: The Guatemala STD Inoculation Studies: What Should We Do Now?
    Nov 13 2012

    The Guatemala STD Inoculation Studies: What Should We Do Now?

    In the late 1940s, U.S. and Guatemalan researchers conducted a host of experiments on vulnerable Guatemalan subjects, purposefully exposing them to and infecting them with a number of STDs without their consent. The experiments were kept hidden for more than half a century, until they were discovered and exposed only recently by historian Susan Reverby.…

  • Read more: Massachusetts: A Community Approach to Quality, Affordable Health Care
    Nov 13 2012

    Massachusetts: A Community Approach to Quality, Affordable Health Care

    Six years after passing the groundbreaking health care access law that became the model for national reform, Massachusetts has once again led the nation through legislation setting a limit on the growth of health care cost. What progress has the state’s health care community made on cost so far, and what will it take to…

  • Read more: Advances in HIV Prevention: Legal, Clinical, and Public Health Issues
    Nov 5 2012

    Advances in HIV Prevention: Legal, Clinical, and Public Health Issues

    On July 3, 2012, FDA approved OraQuick, the first at-home HIV test available for sale directly to consumers, allowing individuals to self-test and receive confidential results in about 20 minutes. Then on July 16, FDA approved once-daily Truvada, an already-approved HIV therapy, as the first agent approved for pre-exposure prophylaxis in uninfected, at-risk adults. These…

  • Read more: Institutional Financial Conflicts of Interest in Research Universities
    Nov 2 2012

    Institutional Financial Conflicts of Interest in Research Universities

    Recording

    Following the turn of the twenty-first century and the burst of the “IT Bubble,” we have seen the collapse of large publicly traded firms like Enron and WorldCom, as well as their auditing firm, Arthur D. Anderson. Soon after, in 2008, the financial crash led to the collapse of Bear Stearns, Merrill Lynch, Countrywide, and…

  • Read more: Obamacare on Trial: A Book Talk with Einer Elhauge
    Nov 1 2012

    Obamacare on Trial: A Book Talk with Einer Elhauge

    A panel discussion on the Petrie-Flom Center’s Founding Faculty Director Einer Elhauge’s book Obamacare on Trial. Panelists

  • Read more: Health Law Workshop: Michele Goodwin
    Oct 29 2012

    Health Law Workshop: Michele Goodwin

    Presentation Fetal Protection Laws: Moral Panic & The New Constitutional Battlefront Michele Goodwin This paper is not available for download.